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Abstract
Background: Rhodnius prolixus is a major vector of Trypanosoma cruzi, the causative agent of Chagas disease in
Latin America. In natural habitats, these insects are in contact with a variety of bacteria, fungi, virus and parasites
that they acquire from both their environments and the blood of their hosts. Microorganism ingestion may trigger
the synthesis of humoral immune factors, including antimicrobial peptides (AMPs). The objective of this study was
to compare the expression levels of AMPs (defensins and prolixicin) in the different midgut compartments and the
fat body of R. prolixus infected with different T. cruzi strains. The T. cruzi Dm 28c clone (TcI) successfully develops
whereas Y strain (TcII) does not complete its life- cycle in R. prolixus. The relative AMP gene expressions were
evaluated in the insect midgut and fat body infected on different days with the T. cruzi Dm 28c clone and the Y
strain. The influence of the antibacterial activity on the intestinal microbiota was taken into account.
Methods: The presence of T. cruzi in the midgut of R. prolixus was analysed by optical microscope. The relative
expression of the antimicrobial peptides encoding genes defensin (defA, defB, defC) and prolixicin (prol) was
quantified by RT-qPCR. The antimicrobial activity of the AMPs against Staphylococcus aureus, Escherichia coli and
Serratia marcescens were evaluated in vitro using turbidimetric tests with haemolymph, anterior and posterior
midgut samples. Midgut bacteria were quantified using colony forming unit (CFU) assays and real time quantitative
polymerase chain reaction (RT-qPCR).
Results: Our results showed that the infection of R. prolixus by the two different T. cruzi strains exhibited different
temporal AMP induction profiles in the anterior and posterior midgut. Insects infected with T. cruzi Dm 28c
exhibited an increase in defC and prol transcripts and a simultaneous reduction in the midgut cultivable bacteria
population, Serratia marcescens and Rhodococcus rhodnii. In contrast, the T. cruzi Y strain neither induced AMP gene
expression in the gut nor reduced the number of colony formation units in the anterior midgut. Beside the
induction of a local immune response in the midgut after feeding R. prolixus with T. cruzi, a simultaneous systemic
response was also detected in the fat body.
Conclusions: R. prolixus AMP gene expressions and the cultivable midgut bacterial microbiota were modulated in
distinct patterns, which depend on the T. cruzi genotype used for infection.
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Background
Trypanosoma cruzi is a protozoan parasite transmitted
to vertebrate hosts by triatomine insects and is the causa-
tive agent of Chagas disease [1, 2]. This disease is a public
health problem, and it is estimated that approximately 6
to 7 million people are infected with T. cruzi worldwide,
mostly in Latin America [3]. Rhodnius prolixus has been
considered one of the most efficient T. cruzi vector in
South America [2, 4]. Consequently, the medical import-
ance of this species has stimulated studies of its physi-
ology, immunology and molecular biology, especially in
experimental infections with T. cruzi [5–12]. Other im-
portant reasons to study R. prolixus include its rapid de-
velopmental cycle and ease of colonization in laboratories
compared to other triatomine species [13].
T. cruzi exhibits a variety of genotypes with a wide range
of heterogeneous populations that circulate through verte-
brate and invertebrate hosts [14, 15]. Many morphological,
physiological and ecological variations of this parasite, in-
cluding its infectivity and pathogenicity [16–18], may ex-
plain the various clinical manifestations of Chagas disease
observed in different geographic regions [19]. Currently,
the intraspecific nomenclature of T. cruzi is based on
grouping populations into six discrete typing units (DTUs)
from TcI to TcVI [20].
The various T. cruzi genotypes differ in their success
at developing inside the digestive tract of different triato-
mine species [21, 22]. Previous studies have demonstrated
that the T. cruzi Y strain, classified as TcII, cannot colonize
the gut of R. prolixus, while the T. cruzi Dm 28c clone,
classified as TcI, successfully infects R. prolixus [20, 23,
24]. Many factors intrinsic to the invertebrate host have
been linked to parasite development, including the activa-
tion of humoral immune responses and the influence of
natural gut bacterial microbiota [22, 23, 25].
Humoral immunity in insects is composed of a num-
ber of effector molecules that are rapidly synthesized
after microorganism invasion. One important humoral
response is the production of inducible antimicrobial
peptides (AMPs) [26, 27]. AMPs are mainly synthesized
by fat body cells and can diffuse into the haemolymph,
which circulates around the entire insect body. Conse-
quently, AMPs are able to control infection [28, 29].
AMPs are also produced in other insect tissues such as
gut epithelial cells, where parasites might interact dir-
ectly and induce the local synthesis and release of these
molecules [30].
Similar to most animals, insects contain a rich natural
gut microbiota, which is essential for diverse functions
in the host such as digestion and vitamin production
[30, 31]. These observations raise the important question
of how insects manage AMP synthesis after parasite in-
fection while maintaining the intestinal bacterial micro-
biota population. A previous study of the R. prolixus - T.
cruzi interaction revealed that the infective T. cruzi Dm
28c clone causes a decrease in the cultivable gut bac-
teria, unlike the non-infective T. cruzi Y strain [10].
Moreover, differential T. cruzi susceptibility to lytic ac-
tivity from the bacteria Serratia marcescens, which is
commonly present in the midgut of R. prolixus, has been
observed [23, 32]. These results suggest that the success
of T. cruzi colonisation in the R. prolixus midgut de-
pends on the parasite DTU and its capacity to interact
with the natural vector microbiota. The aim of this study
was to investigate the influence of T. cruzi infection on
the spatial and temporal expression of antimicrobial
peptides in R. prolixus and gut microbiota.
Methods
Rhodnius prolixus maintenance and ethics statement
R. prolixus were maintained in a colony at Laboratório
de Bioquímica e Fisiologia de Insetos, Instituto Oswaldo
Cruz, under controlled temperature and humidity. The
insects were fed defibrinated rabbit blood provided by
the Centro de Criação de Animais de Laboratório (Cecal)
in an artificial apparatus [13]. The rabbit blood was ob-
tained according to the Ethical Principles in Animal
Experimentation approved by the Comissão de Ética no
Uso de Animais do Instituto Oswaldo Cruz (CEUA/IOC)
under the protocol number L-0061/08 developed by
Conselho Nacional de Experimentação Animal/Ministério
de Ciência e Tecnologia CONCEA/MCT [33].
Trypanosoma cruzi culture
The T. cruzi Dm 28c clone [34] and T. cruzi Y strain
[35], previously classified as TcI and TcII, respectively
[20], were maintained as epimastigote forms at 28 °C in
brain heart infusion (BHI) media (Sigma-Aldrich) contain-
ing hemin and supplemented with 10 % heat-inactivated
bovine foetal serum [13]. For insect infection, the parasites
were used in the exponential growth phase. The number
of parasites was quantified in a Neubauer chamber using
an optical microscope.
Bacteria cultures
Escherichia coli K12 4401 and Staphylococcus aureus
9518 were obtained from the National Collection of
Industrial and Marine Bacteria (NCIMB), Aberdeen, UK.
Serratia marcescens RPH was previously isolated from R.
prolixus and maintained at Laboratório de Bioquímica e
Fisiologia de Insetos. All bacteria were kept at−70 °C in
tryptone agar and 10 % glycerol.
Rhodnius prolixus oral infection
Fifth instar nymphs were randomly chosen and fed with
defibrinated rabbit blood containing T. cruzi epimastigotes
of the Dm 28c clone or Y strain. The blood complement
system was previously heat- inactivated by centrifugation
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at 1890 × g for 15 min at 4 °C and incubation of the
plasma (supernatant) for 30 min at 55 °C. Subsequently,
the plasma was mixed with phosphate buffered saline
(PBS)-washed erythrocytes, and the parasites were added
to the reconstituted blood at a final concentration of
1 × 107 epimastigotes/mL. Additionally, groups of in-
sects received a blood meal containing a combination of
two antibiotics (penicillin and ampicillin) with or with-
out T. cruzi Dm 28c epimastigotes. Each antibiotic was
administrated in a final concentration of 300 μg/ml of
blood. Uninfected control insects were fed on inactivated
blood without parasites. Only fully engorged fifth instar R.
prolixus nymphs were used for the experiments.
T. cruzi quantification in the R. prolixus midgut
The entire digestive tract was dissected and individually
homogenized in 1.0 mL PBS. The parasites were counted
using a Neubauer haemocytometer as previously de-
scribed [36].
Quantification of the R. prolixus bacterial midgut
microbiota (CFU)
The anterior and posterior midgut were separately dis-
sected from fifth instar nymphs infected or uninfected
with T. cruzi (n = 9). The cultivable microbiota popula-
tion was quantified by counting the colony forming units
(CFU) 7 days after feeding (DAF) as previously described
[10]. Briefly, the midgut samples were serially tenfold di-
luted with sterile PBS, and 20 μL aliquots of each dilu-
tion were spread on a Petri dish in sterile BHI agar
(Sigma-Aldrich) culture medium. The plates were incu-
bated at 30 °C for 24 h, and the CFUs were quantified.
As control, PBS was plated to check the sterility of the
experiments. Additionally, RT-qPCR was performed
using cDNA from 3 pools of 10 anterior midguts from
different insect groups: control uninfected insects,
treated with antibiotics (as described above), infected
with T. cruzi Dm 28c; treated with antibiotics simultan-
eously infected with T. cruzi Dm 28c epimastigotes.
Haemolymph and midgut antibacterial assays
Anterior and posterior midguts were collected from dis-
sected insects (nine pools of three insects each) and pre-
pared as previously described [12, 36]. Haemolymph
samples were pooled 5 DAF from 10 insects from three
different experiments and diluted 1:1 in ultrapure water
in sterile 1.5 ml tubes containing a few crystals of phen-
ylthiourea to avoid melanisation. The bacteria (S. aureus,
E. coli and S. marcescens) were grown as previously de-
scribed [36]. The antibacterial activity of the insect sam-
ples was assessed by modified turbidimetric assays (TB)
[10]. All experiments were carried out at least in triplicate
(n = 9). The detected antibacterial activities represent the
R. prolixus inducible humoral immune molecules and
other factors produced by midgut microbiota.
Quantification of antimicrobial peptide gene expression
and intestinal bacteria by RT-qPCR
Insects at 1 and 7 DAF (T. cruzi infected and non-
infected) were dissected to prepare three pools each of
five anterior midguts, posterior midguts and fat body as
previously described [12]. Total RNA was extracted
using a NucleoSpin® RNA II Kit (Macherey-Nagel,
Düren, Germany) following the manufacturer’s instruc-
tions and quantified using a NanoDrop 2000 Spectro-
photometer (Thermo Scientific, Waltham, MA, USA).
Synthesis of cDNA was carried out with a First-Strand
cDNA Synthesis Kit (GE Healthcare, Buckinghamshire,
UK) following the manufacturer’s protocol using 2.5 μg
of total RNA and the pd(N)6 primer. cDNA was quanti-
fied by fluorescence using a Qubit Fluorimeter (Life
Technologies) with the ssDNA assay kit. Real-time
quantitative polymerase chain reactions (RT-qPCR) were
conducted using an ABIPRISM 7500 Sequence Detec-
tion System (Applied Biosystems) at the PDTIS/FIO-
CRUZ facilities (Real-Time PCR Platform RPT-09A).
The present study analysed the gene expression of three
R. prolixus defensins (defA, defB and defC) and prolixi-
cin (prol). The specific primers for the AMP genes, R.
prolixus reference genes and 16S rRNA primers for rela-
tive quantification of S. marcescens and R. rhodnii were
used as previously published or were designed based on
the respective sequence (Additional file 1) [9, 37, 38],
using the expression of control uninfected insects as cal-
ibrators. Each reaction was run in duplicate for each
pool of insects (n = 3). Each well contained 10 ng cDNA,
primer pairs (0.25 μM) and the qPCR master mix Dy-
NAmo ColorFlash SYBR Green qPCR Kit (Thermo
Fisher Scientific) at a final volume of 20 μl. The cDNA
was amplified at 95 °C for 10 min followed by 40 cycles
of 95°for 15 s and 60 °C for 1 min. As negative controls,
PCR reactions were carried out without cDNA template
to assess primer dimer formation or contamination in
the reactions. A melting curve analysis was carried out
to confirm that only a single product was amplified for
each target. The AMP genes in the tissues of R. prolixus
infected with T. cruzi were quantified by the compara-
tive Ct (ΔΔCt) method [39] normalized with the R. pro-
lixus reference genes α-tubulin and GAPDH. Data were
analysed by the Expression Suite v1.0.3 software (Life
Technologies), considering the amplification efficiency
of each target.
Statistical analysis
All obtained data were analyzed using Student’s T-test
and 1-way ANOVA and the GraphPad Prism 5 software.
Significance levels are shown in the respective figures
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and legends, which were considered statistically different
when p < 0.05.
Results
Quantification of T. cruzi in the R. prolixus midgut
The parasite populations in the entire midgut of the 5th
instar R. prolixus nymphs were quantified from 2 to
7 days after feeding (DAF) with blood containing para-
sites. Two DAF, the average concentration of T. cruzi
Dm 28c (75 × 104 parasites/mL) was ten times higher
than that of T. cruzi Y (7.5 × 104 parasites/mL) in the in-
sect gut (Additional file 2, p < 0.001). On the 5th DAF, a
decrease in the number of parasites from both the T.
cruzi strains was detected, although the T. cruzi Dm 28c
number was two times greater than T. cruzi Y (Add-
itional file 2, p < 0.01). Moreover, no T. cruzi Y strain
parasites were detected in the R. prolixus gut samples
analysed on the 7th DAF, while on the same day the T.
cruzi Dm 28c population increased in all insect guts ana-
lysed (Additional file 2).
Analysis of the R. prolixus midgut microbiota-colony
forming units (CFU) and RT-qPCR
The cultivable bacterial microbiota population in the 5th
instar nymphs infected with T. cruzi was evaluated sep-
arately for the anterior and posterior midgut using CFU
counts. Infection with both T. cruzi strains significantly
reduced the bacterial population in the R. prolixus anter-
ior midgut on the 7th DAF. However, T. cruzi Dm 28c
caused a stronger CFU reduction (p < 0.001) (2.5 ×
108 CFU/mL−26-fold less) than T. cruzi Y (p < 0.05)
(1.64 × 109 CFU/mL−4-fold less) in comparison with un-
infected insects (6.57 × 109 CFU/mL) (Fig. 1). T. cruzi in-
fection did not significantly alter the CFU counts in the
posterior midgut compared with control insects.
After T. cruzi Dm 28c infection a 2.6-fold reduction
of the S. marcescens bacterial number was detected
(Additional file 3A, p < 0.01) and the R. rhodnii load de-
creased 3.5-fold (Additional file 3B, p < 0.01) in the anterior
midgut. In insects treated with antibiotics, S. marcescens
was reduced 10-fold (Additional file 3A, p < 0.001) whereas
the R. rhodnii population increased 3-fold (Additional
file 3B, p < 0.001). Data were always compared to con-
trol insects fed only on blood.
Fig. 1 Bacteria populations in the Rhodnius prolixus midgut infected
with Trypanosoma cruzi. Colony forming units (CFU) were counted in
the anterior and posterior midgut samples seven days after feeding
the insects with blood at a final concentration of 1 × 107 epimastigotes/mL.
Insect treatments: black columns-control insects (C); grid columns-T.
cruzi Dm 28c clone-infected insects (Dm 28c); striped columns-T. cruzi
Y strain-infected insects (Y). Bars represent the mean ± SEM of three
independent experiments with nine pools of insects (n = 9). Means
were compared using Student’s T-test or Mann—Whitney test;
*** p < 0.001, * p < 0.05
Fig. 2 Antibacterial activities in haemolymph samples of Rhodnius prolixus infected with Trypanosoma cruzi. R. prolixus 5th instar nymphs were fed
inactivated blood containing the T. cruzi Dm 28c clone or Y strain at a final concentration of 1 × 107 epimastigotes/mL. The antibacterial activities
were assayed with haemolymph collected five days after infection and tested against (a) E. coli or (b) S. aureus. Haemolymph samples were
prepared from: black columns-control, uninfected insects; grid columns-infected with T. cruzi Dm 28c; striped columns-infected with T. cruzi Y
strain. Antibacterial activity was measured through optical densities using the turbidimetric assay (OD550 nm) after 19 h of incubation of haemolymph
samples with bacteria. Bars represent the mean ± SEM of three independent experiments with nine pools of insects (n = 9). Means were compared
using one-way ANOVA and Student’s T-test; *** p < 0.001, ** p < 0.01
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Haemolymph and midgut antibacterial detection
The R. prolixus haemolymph antibacterial activity was
demonstrated using TB assays. The haemolymph of un-
infected control insects demonstrated antibacterial activ-
ities that inhibited the growth of both Gram-negative
and Gram-positive bacteria (Fig. 2). However, haemo-
lymph from both the T. cruzi infected insect groups ex-
hibited significantly higher antibacterial activity than the
haemolymph samples from the control insects (Fig. 2a,
p < 0.001; Fig. 2b, p < 0.001).
The optical densities of the R. prolixus anterior midgut
incubated with different bacteria showed that only the T.
cruzi Dm 28c infection significantly increased the antibac-
terial activity against S. marcescens (Fig. 3c, p < 0.001).
The activities measured against E. coli and S. aureus in
insects infected with both T. cruzi strains were not sta-
tistically significant compared to the control insects
(Fig. 3a, 3b).
Antibacterial assays of the R. prolixus posterior midgut
samples demonstrated that only T. cruzi Dm 28c infection
induced an increase in the antibacterial activity against E.
coli (Fig. 4a, p < 0.01). No differences were observed for
the activities against S. aureus in insects infected with the
two T. cruzi strains compared to the control insects in this
same midgut compartment (Fig. 4b).
Quantification of antimicrobial peptide gene expression
(RT-qPCR)
Modulations in the expression of AMP genes in the R.
prolixus 5th instar nymphs infected with T. cruzi Dm 28c
and T. cruzi Y strain were verified in different tissues at
1 and 7 DAF. All data obtained here were compared to
the gene expression in control insects, which was given
the value 1.0 and is represented in the figures as hori-
zontal dotted lines along the Y-axis. Expression of prol
in both the T. cruzi Dm 28c and Y strains was signifi-
cantly upregulated at the transcript level in the fat body
on the 7th DAF in comparison to control insects (Fig. 5a,
p < 0.05). However, only the T. cruzi Dm 28c infection
modulated prol expression in the R. prolixus midgut,
with distinct patterns in the different compartments. In
the anterior midgut, prol transcript levels were signifi-
cantly lower in infected insects than in controls on the
1st DAF (Fig. 5a, p < 0.001). On the 7th DAF, the prol
transcript levels had increased by 2.5-fold in this same
midgut compartment of T. cruzi Dm 28c-infected in-
sects (Fig. 5b, p < 0.05). However, the opposite pattern
was observed in the posterior midgut, where the prol ex-
pression was 10-fold higher in the T. cruzi Dm 28c-
infected insects on the 1st DAF (Fig. 5c, p < 0.001), while
on the 7th DAF the prol transcript levels decreased,
reaching the same levels as in the control insects
(Fig. 5c). Additionally, the T. cruzi Y strain-infected in-
sects exhibited prol gene expression similar to control
insects in both the anterior and posterior midgut on the
1st and 7th DAF (Fig. 5b, c).
Infection of R. prolixus with both the T. cruzi Dm 28c
and Y strains down regulated the defA levels on the 1st
Fig. 3 Antibacterial activity in the anterior midgut of Rhodnius prolixus
infected with Trypanosoma cruzi. R. prolixus 5th instar nymphs were fed
inactivated blood containing the T. cruzi Dm 28c clone or Y strain at
a final concentration of 1 × 107 epimastigotes/mL. The antibacterial
activities were measured in vitro in anterior midgut samples seven
days after infection and tested against (a) E. coli, (b) S. aureus and
(c) S. marcescens. Treatments: black columns-uninfected insects; grid
columns-T. cruzi Dm 28c-infected insects; striped columns-T. cruzi
Y-infected insects. Antibacterial activity was measured through
optical densities using the turbidimetric assay (OD550 nm) after 19 h
of incubation of anterior midgut samples with bacteria. Bars represent
the mean ± SEM of three independent experiments with nine pools of
insects (n = 9). Means were compared using one-way ANOVA and
Student’s T-test; *** p < 0. 001, NS = not significant
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DAF in the fat body (Fig. 6a, p < 0.01). On the 7th DAF, a
significant 2-fold increase was detected in the defA levels
in the T. cruzi Dm 28c-infected insects (Fig. 6a, p < 0.05),
while the T. cruzi Y-infected insects presented the same
gene levels as the control (Fig. 6a). In the anterior midgut,
only the infection with T. cruzi Y modulated the defA
transcript levels, which were significantly lower than in
the control insects (Fig. 6b, p < 0.05).
The ingestion of T. cruzi Y down regulated the defB
levels on the 1st DAF in the R. prolixus fat body and mid-
gut (Fig. 6c, p < 0.05; Fig. 6d, p < 0.01). However, T. cruzi
Dm 28c significantly upregulated defB levels in the anter-
ior midgut, but only on the 1st DAF (Fig. 6d, p < 0.05). No
defB transcripts were detected in the anterior midgut on
the 7th DAF for either of the T. cruzi strains (Fig. 6d).
Both T. cruzi strains strongly induced defC expression
in the insect fat body on the 1st DAF. While T. cruzi Dm
28c increased defC levels 11-fold (Fig. 7a, p < 0.001), T.
cruzi Y increased defC 24-fold (Fig. 7a, p < 0.001) com-
pared with non-infected insects. In the anterior and
posterior midgut, only T. cruzi Dm 28c significantly up-
regulated defC levels on the 7th DAF (Fig. 7b, p < 0.001;
Fig. 7c, p < 0.05), whereas T. cruzi Y down regulated
these genes in the posterior midgut on the 7thDAF
(Fig. 7c, p < 0.01).
In insects fed on blood containing antibiotics defC ex-
pression decreased 1.72-fold (Additional file 4, p < 0.05)
in the anterior midgut when compared to control non-
infected insects. However, in insects treated with antibi-
otics and infected with T. cruzi Dm 28c, defC expression
was 4-fold higher (Additional file 4, p < 0.01) in comparison
to T. cruzi infected insects without antibiotics treatment
and 14-fold higher than control, uninfected (Additional
file 4, p < 0.001). Summary of all results obtained are
shown in Additional files 5 and 6.
Discussion
This study attempted to understand the influence of T.
cruzi Dm 28c and T. cruzi Y infections on the modula-
tion of AMP gene expression and antibacterial activity
in different R. prolixus tissues, thereby altering the gut
bacterial microbiota and parasite survival. It has already
been demonstrated that T. cruzi Y strain is rapidly lysed,
while T. cruzi Dm 28c complete its life-cycle in the gut
of R. prolixus [10, 23]. Comparing the infection of these
two T. cruzi genotypes in R. prolixus, we found that Dm
28c induced:(i) a reduction of the CFU bacterial number,
(ii) an increase of antibacterial activity against S. marces-
cens, (iii) an enhancement of prol and defC expression,
and (iv) a decrease of S. marcescens and R. rhodnii load in
the anterior midgut. In the present study, the insects fed
on blood containing both antibiotics and T. cruzi Dm 28c,
defC expression increased 4-fold in comparison to in-
fected insects lacking antibiotics. In this context, a previ-
ous study demonstrated that R. prolixus fed on blood
containing T. cruzi Dm 28c and antibiotics presented sig-
nificantly increased parasite numbers and a reduced cul-
tivable bacterial population in the midgut [10]. Together,
all these findings suggest a regulatory function of defensin
C on R. prolixus microbiota, promoting the reduction of
intestinal bacteria number and subsequently the parasite
development. S. marcescens - one cultivable bacteria com-
monly found in the triatomine’s gut- has been associated
with trypanolytic effects [23, 36, 40, 41]. This cytotoxic
bacterium is a natural barrier that influences the establish-
ment of parasites [6, 10, 23]. In contrast to Dm 28c, T.
cruzi Y strain is apparently not able to stimulate the local
immune response and overcome this barrier.
Antimicrobial effects of recombinant AMP prolixicin
have been assayed against different Gram-negative bac-
terial species, showing higher activity against E. coli than
Fig. 4 Antibacterial activity in the posterior midgut of Rhodnius prolixus infected with Trypanosoma cruzi. R. prolixus 5th instar nymphs were fed
inactivated blood containing the T. cruzi Dm 28c clone or Y strain at a final concentration of 1 × 107 epimastigotes/mL. The antibacterial activities
were measured in vitro in posterior midgut samples seven days after infection and tested against (a) E. coli and (b) S. aureus. Treatments: black
columns-uninfected insects; grid columns-T. cruzi Dm 28c-infected insects; striped columns-T. cruzi Y-infected insects. Antibacterial activity was
measured through optical densities using the turbidimetric assay (OD550 nm) after 19 h of incubation of posterior midgut samples with bacteria.
Bars represent the mean ± SEM of three independent experiments with nine pools of insects (n = 9). Means were compared using one-way
ANOVA and Student’s T-test; * p < 0.05
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S. marcescens [9]. Here, the synergistic effects of prolixi-
cin associated with the effects of defensin C could
explain the increased antibacterial activity against S.
marcescens and the decrease of R. rhodnii and S. marces-
cens bacterial load in the anterior midgut after T. cruzi
Dm 28c infection. On the other hand, R. prolixus
infected with the T. cruzi strain Chile 5 did not exhibit a
reduced R. rhodnii population [42]. These results suggest
that the capacity of T. cruzi to colonize the R. prolixus
midgut might depend on its genotypic characteristics
combined with its ability to modulate (directly or indir-
ectly) the host natural microbiota. In a recent study, the
silencing of rpRelish (Nf-κB transcription factor of
AMPs in the IMD pathway) resulted in an increase of R.
rhodnii CFU, which did not affect T. cruzi Dm 28c clone
development in R. prolixus midgut [43].
Many studies have described how the intestinal micro-
biota of insect vectors affect the life-cycle of parasites,
including nutrient competition between these microor-
ganisms [44, 45]. Native bacteria in the Anopheles mid-
gut negatively affect certain species of Plasmodium by
direct contact between the microorganisms involved and
by the induction of the immune response mediated by
commensal bacteria [46–48]. In contrast, parasitic infec-
tions capable of modulating immune peptide synthesis
in insect hosts [36, 49, 50] might interfere with the
growth of certain bacteria species of the microbiota, as
seems to occur in Trypanosoma rangeli infection in R.
prolixus [36]. Moreover, serine protease inhibitors from
the Kazal family in the anterior midgut of T. cruzi-in-
fected R. prolixus were recently shown to be involved in
the modulation of the intestinal microbiota [51].
The presence of bacteria or parasites in the digestive tract
stimulates the systemic secretion of AMPs into the haemo-
lymph of different insects, including species of Phlebotomus,
Glossina and Drosophila, even without the invasion of
these microorganisms into the haemocoel [49, 52–54].
After induction of AMP gene expression in the fat body,
the respective peptides are initially secreted directly into
the haemolymph. Later, the AMPs can diffuse through-
out the insect body, representing a systemic response to
oral parasite infection [29]. The induction of AMP ex-
pression in the fat body by parasites confined to the mid-
gut could be due to immune signalling by molecules
such as nitric oxide (NO), representing a host anticipa-
tion strategy to prevent a widespread infection [54, 55].
A similar pattern was observed in this study. The oral In-
fection of R. prolixus by both T. cruzi genotypes triggered
a rapid increase of the defC gene transcriptional levels in
the fat body. High levels of mature DefC in the fat body
might be directly related to the increased antibacterial
activity detected in vitro in the haemolymph.
During T. cruzi Dm 28c development in R. prolixus,
higher numbers of epimastigotes are found in the anter-
ior midgut until the fifth day after infection. Thereafter,
they tend to inhabit the posterior midgut [56]. One day
after T. cruzi Dm 28c infection, reduced prol levels were
found in the anterior midgut, while prol levels had in-
creased in posterior midgut. The T. cruzi Y infection
was not capable of upregulating the expression of the
Fig. 5 Spatial and temporal prolixicin relative gene expression in
Rhodnius prolixus orally infected with Trypanosoma cruzi. R. prolixus
5th instar nymphs were fed inactivated blood containing the T. cruzi
Dm 28c clone or Y strain at a final concentration of 1 × 107
epimastigotes/mL. Data were quantified using the gene expression
of uninfected insects as the calibrator represented by the dotted
horizontal line on each graph and shown as the relative prol
expression in the (a) fat body, (b) anterior midgut and (c) posterior
midgut on the 1st and 7th days after feeding (DAF). Treatments: grid
columns-relative prol expression in insects infected with T. cruzi Dm
28c; striped columns-relative prol expression in insects infected with
T. cruzi Y. Bars represent the mean ± SEM of two independent
experiments with six pools of insects (n = 6). Means were compared
using one-way ANOVA and Student’s T-test; *** p < 0.001, * p < 0.05
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analysed AMPs in the R. prolixus midgut. The expres-
sion of AMPs in intestinal epithelial cells is considered a
local immune response activated by the direct contact of
the parasites with the insect tissue [29, 57]. Here, the
systemic response of R. prolixus to the different parasite
strains was similar, although local responses to TcI and
TcII infection exhibited differing profiles.
The parasite P. berghei modulates defensin gene expres-
sion in the gut and salivary gland epithelium of Anopheles
gambiae, tissues where the parasite is found during its
life-cycle [58]. Leishmania major infection also induces
defensin expression in the haemolymph and midgut of
the insect Phlebotomus duboscqi [49], although infec-
tion by Leishmania mexicana totally abolished def1 ex-
pression in Lutzomyia longipalpis [50]. Interestingly, the
infection of R. prolixus with the T. rangeli Macias strain
also upregulated defC levels in the midgut regions
where the parasite was found [36]. In the present study,
the presence of T. cruzi Dm 28c in different midgut re-
gions had a similar effect, enhancing defC expression.
These results support the hypothesis that defensin genes
are modulated by protozoan infections in insects and
not directly by the CFU bacterial microbiota population.
Several defensin-encoding genes have been identified
in different triatomine species [11, 37, 59–61]. After the
analysis of the primary defensin structure and the tran-
script abundance of defensin-encoding genes in T.
brasiliensis, it was proposed that these peptides have dif-
ferent biological targets [60]. In agreement, the three R.
prolixus defensin encoding genes were differently
expressed in response to the invading microorganism. In
the present work, only defC was up regulated by T. cruzi
Dm 28c, 7 DAF in the R. prolixus midgut. A similar re-
sult was also observed in T. rangeli infected insects [36].
On the other hand, defA and defB were upregulated in
the midgut in response to Gram-positive bacterial oral
infection [12].
Prolixicin was recently identified in R. prolixus haemo-
lymph and shows structural similarities with another
AMP family, the attacins [9]. The influence of attacins
on the establishment of Trypanosoma brucei was previ-
ously demonstrated in the tsetse fly [62, 63]. T. brucei
infection upregulated the attacin genes in the fat body
and midgut of the insect vector. In addition, insects
naturally resistant to T. brucei infection present high
levels of attacin even in non-infected flies, suggesting
that this AMP interferes with T. brucei development
[62, 63]. Attacin and prolixicin possess high toxicity
against the Gram-negative E. coli [9, 62], suggesting
that the structural similarity between these AMPs
may also extend to their microbial targets. Because
prolixicin shares similar characteristics with attacins,
this AMP may also have a toxic effect against trypa-
nosomatids. The prolixicin gene expression seems to
be downregulated according to the local concentration
of T. cruzi epimastigotes, as observed in experimental
infections with the T. rangeli Macias strain that suc-
cessfully infects the R. prolixus midgut [36]. The
Fig. 6 Spatial and temporal defensin A and B relative gene expression in Rhodnius prolixus orally infected with Trypanosoma cruzi. R. prolixus 5th
instar nymphs were fed inactivated blood containing the T. cruzi Dm 28c clone or Y strain at a final concentration of 1 × 107 epimastigotes/mL.
Data were quantified using the gene expression of uninfected insects as the calibrator, represented by the dotted horizontal line on each graph,
and shown as the relative expression of (a) defA in the fat body, (b) defA in the anterior midgut, (c) defB in the fat body and (d) defB in the
anterior midgut on the 1st and 7th days after feeding (DAF). Treatments: grid columns-relative gene expression in insects infected with T. cruzi Dm
28c; striped columns-relative gene expression in insects infected with T. cruzi Y. Bars represent the mean ± SEM of two independent experiments
with six pools of insects (n = 6). Means were compared using one-way ANOVA and Student’s T-test; ** p < 0.01, * p < 0.05, ND = not determined
Vieira et al. Parasites & Vectors  (2016) 9:119 Page 8 of 12
results obtained from T. cruzi infection in R. prolixus
suggest that suppression of prol genes may represent
one survival mechanism of trypanosomatids in the
insect gut.
The genetic variability of T. cruzi is expressed in dif-
ferent compositions of cell surface molecules, such as
sugars and proteins [64]. T. cruzi populations belonging
to the TcI genotype contain more galactose residues in
their cell surfaces than the TcII populations [65]. Mem-
brane proteins such as the virulence factor trans-
sialidase are also differently distributed in TcI and TcII
genotypes [66]. Other membrane-bound proteins of T.
cruzi, such as mucins, interact by the adhesion of the fla-
gellum to the epithelial cell and perimicrovillar mem-
branes of the midgut, a crucial step for parasite
development and infectivity [67]. The role of trans-
sialidases and mucins as virulent factors in the recogni-
tion of T. cruzi and in the induction of specific immune
responses has been demonstrated in vertebrate models
[68–70]. Therefore, the distinct immune response results
obtained in the present study from R. prolixus infection
by the two T. cruzi strains might be an effect of differ-
ences on T. cruzi membrane structures. Because R. pro-
lixus is predominantly infected with TcI [71, 72], this
genotype may be better adapted to this triatomine spe-
cies due to a modulation of the immune response
favouring the establishment of the parasite.
Currently, efforts to control human diseases transmit-
ted by insects are focused on vector control, specifically
in the construction of genetically modified intestinal
bacteria that control their natural parasites by recom-
binant expression of an AMP or by RNAi [73, 74].
Knowledge about how different T. cruzi genotypes
modulate antimicrobial peptide expression in R. pro-
lixus can assist in selecting the genes to be manipu-
lated. RNAi technology is an interesting tool to verify
in the future the effect of each AMP gene expression
on the parasite development and on the gut microbiota
composition of R. prolixus. It would also be important
to perform studies using aposymbiotic insects - which
might have an effect on the triatomine immunity - to
clarify the specific effects of each bacteria species and
T. cruzi infections. However, these conditions would be
artificial as in nature insects are frequently found inha-
biting a great variability of bacterial species in the in-
testine and are infected with T. cruzi simultaneously
[41]. To further clarify the tripartite relation between
parasites, microbiota and insects, the measurement of
protein levels and proteomic analyses will be useful in
the future.
Conclusions
T. cruzi Dm 28c-infected R. prolixus showed increased
defC and prol expression levels in the anterior midgut
and a higher antibacterial activity against S. marcescens
that could be related to the drastic reduction of the cul-
tivable bacterial microbiota, S. marcescens and R. rhod-
nii. In contrast, these effects were not observed in
insects infected with the T. cruzi Y strain, which might
explain why this strain does not develop in R. prolixus.
Fig. 7 Spatial and temporal defensin C relative gene expression in
Rhodnius prolixus orally infected with Trypanosoma cruzi. R. prolixus
5th instar nymphs were fed inactivated blood containing the T. cruzi
Dm 28c clone or Y strain at a final concentration of 1 × 107
epimastigotes/mL. Data were quantified using the gene expression
of uninfected insects as the calibrator, represented by the dotted
horizontal line on each graph, and shown as the defC relative
expression in the (a) fat body, (b) anterior midgut and (c) posterior
midgut on the 1st and 7th days after feeding (DAF). Treatments: grid
columns-defC relative expression in insects infected with T. cruzi Dm
28c; striped columns-defC relative expression in insects infected with
T. cruzi Y. Bars represent the mean ± SEM of two independent
experiments with six pools of insects (n = 6). Means were compared
using one-way ANOVA and Student’s T-test; *** p < 0.001, ** p <0.01,
* p < 0.05
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Additional file 1: Oligonucleotide primers used for qPCR analysis.
(DOC 46 kb)
Additional file 2: Parasite population in Rhodnius prolixus digestive tract.
The numbers of T. cruzi Dm 28c and Y strain parasites were estimated in
the whole digestive tracts of R. prolixus 5th instar nymphs at different
days after feeding (DAF). Each point represents the number of parasites
in an individual insect, and bars indicate the median. Means were
compared using Student’s T-test or Mann-Whitney test;
*** p < 0.001, * p < 0.05. (BMP 64 kb)
Additional file 3: Determination of bacterial load in the anterior midgut
of Rhodnius prolixus after antibiotic treatment and Trypanosoma cruzi Dm
28c infection by RT-qPCR. R. prolixus anterior midgut were analysed 7 days
after feeding on inactivated blood containing antibiotics (ampicillin
300 μg/ml plus penicillin 300 μg/ml of blood) and T. cruzi Dm 28c clone
at a final concentration of 1 × 107 epimastigotes/mL. Relative expression
of 16S-rRNAS of A−Serratia marcescens B−Rhodococcus rhodnii. Treatments:
black column—control insects fed only on blood; white column-insects fed
on blood containing antibiotics; grid column-insects fed on blood
containing T. cruzi; striped columns-insects fed on blood containing
antibiotics and T. cruzi. Two biological samples in triplicate were used
for each group. All data were normalized to the R. prolixus α-tubulin,
representing the mean of identical triplicates ± standard error. Bars
represent the mean ± SEM of 3 independent experiments with 3 pools of
insects (n= 3). Means were compared using Student’s T-test; *** p < 0.001,
** p < 0.01, * p < 0.05, NS indicates a non-significant difference. (TIF 244 kb)
Additional file 4: Defensin C relative gene expression in the anterior
midgut of Rhodnius prolixus fed on blood containing antibiotics and
Trypanosoma cruzi. DefC gene expression in R. prolixus anterior midgut
were analysed 7 days after feeding on inactivated blood containing
antibiotics (ampicillin 300 μg/ml plus penicillin 300 μg/ml of blood) and
T. cruzi Dm 28c clone at a final concentration of 1 × 107 epimastigotes/mL.
Treatments: black column-control insects fed only on blood; white column-
insects fed on blood containing antibiotics; grid column-insects fed on
blood containing T. cruzi; striped columns-insects fed on blood containing
antibiotics and T. cruzi. Bars represent the mean ± SEM of 3 independent
experiments with 3 pools of insects (n = 3). Means were compared using
Student’s T-test; *** p < 0.001, ** p < 0.01, * p < 0.05. (TIF 403 kb)
Additional file 5: Summary table of colony forming unit (CFU) and
antibacterial activity against distinct Gram-negative and Gram-positive
bacteria of R. prolixus midgut and haemolymph, 7 days after T. cruzi
infection. (DOCX 12 kb)
Additional file 6: Summary table of antimicrobial peptides (AMP) gene
expression in R. prolixus midgut and fat body, 1 and 7 days after T. cruzi
infection. (DOCX 13 kb)
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